Can a Common Diabetes Drug Really Cut Dementia Risk in Half?
According to Parade, a new study suggests that liraglutide, a medication used for diabetes and weight loss, might reduce the risk of dementia by up to 50%.
This research, presented recently at a major Alzheimer’s conference, is still unpublished, but it shows promising results.
In the study, participants who took liraglutide had less brain shrinkage and cognitive decline compared to those who received a placebo.
Liraglutide is in the same class of drugs as Ozempic and Wegovy, which are known for weight loss and managing diabetes.
Experts think liraglutide might help lower dementia risk because it reduces inflammation and helps manage obesity, which is linked to a higher risk of dementia.
Dr. Paul Edison from Imperial College London led the study, and while the exact reasons for the drug’s effects on the brain are still being investigated, it could be a breakthrough.
However, it’s important to note that this research is preliminary. Dr. Stacey E. Podkovik and Dr. Elizabeth Landsverk suggest that while the findings are exciting, more research is needed.
They recommend focusing on healthy lifestyle choices, like a balanced diet and regular exercise, to support brain health.
For now, if you’re interested in this medication, it’s best to consult with your doctor to see if it’s right for you.
Meanwhile, Parade’s coverage highlights the potential of these drugs but also emphasizes the need for further study.